Abstract:Objective To investigate the relationship of the expressions of substance P (SP) and neurokinin-1 (NK-1R) in nasopharyngeal carcinoma tissues with clinicopathological factors and prognosis.Methods A total of 83 patients with nasopharyngeal carcinoma who were admitted to the hospital from April 2016 to November 2018 were selected as the research group, and 47 patients who underwent nasal septum deviation correction in the hospital during the same period (with normal nasopharyngeal mucosal tissue confirmed by pathology) were selected as the control group. All patients in the study group were followed up for 3 years after treatment. The expressions of SP and NK-1R in nasopharyngeal carcinoma tissues and normal nasopharyngeal mucosa tissues were detected by real-time fluorescence quantitative PCR and immunohistochemistry. The expressions of SP and NK-1R in nasopharyngeal carcinoma tissues and normal nasopharyngeal mucosa tissues were compared. The relationship of SP, NK-1R expression with clinicopathological parameters in cancer tissues of patients with nasopharyngeal carcinoma was analyzed. To analyze the factors affecting the recurrence or metastasis of nasopharyngeal carcinoma patients after treatment. The relationship of SP and NK-1R protein expression in cancer tissue with disease-free survival of patients with nasopharyngeal carcinoma was analyzed.Results The relative expressions of SP and NK-1R mRNA in nasopharyngeal carcinoma tissues were higher than those in normal nasopharyngeal mucosa tissues (P < 0.05). The positive expression rates of SP and NK-1R in nasopharyngeal carcinoma tissues were higher than those in normal nasopharyngeal mucosa tissues (P < 0.05). The positive expression rates of SP and NK-1 in cancer tissues of patients with M1 and Ⅲ to Ⅳa nasopharyngeal carcinoma were higher than those of M0 and Ⅰ to Ⅱ stages (P < 0.05), and those of T3 to T4 nasopharyngeal carcinoma The positive expression rate of SP in tissues was higher than that in T1 to T2 stage (P < 0.05). Of the 83 patients with nasopharyngeal carcinoma, 8 were lost to follow-up at the end of follow-up. Cox regression analysis showed: M stage [R^R = 4.958, (95% CI: 2.040, 12.050) ], clinical stage [R^R = 6.593 (95% CI: 2.713, 16.023) ], SP positive [R^R= 4.063 (95% CI: 1.672, 9.875) ], NK-1R positive [R^R = 4.047 (95% CI: 1.665, 9.836) ] were risk factors affecting the recurrence or metastasis of NPC patients after treatment (P < 0.05). Among the 43 SP-positive patients, 34 had disease-free survival, and 32 SP-negative patients had a disease-free survival of 31. The disease-free survival curve of SP negative expression patients was better than patients with SP positive expression (P < 0.05). 29 of 38 patients with positive NK-1R expression and 36 of 37 patients with negative expression of NK-1R. The disease-free survival curve of patients with negative NK-1R expression was better than patients with positive expression (P < 0.05).Conclusion The expression of SP and NK-1R proteins in cancer tissues of patients with nasopharyngeal carcinoma is related to clinicopathological parameters and prognosis. Patients with positive expression of SP and NK-1R have a high risk of recurrence and metastasis.